News and Comments

CHEMOCENTRIX (CCXI): A LEADER OF A NEW LINE OF INVESTIGATIONAL TREATMENTS

  Monday, October 08, 2012

In an effort to find additional small biotech firms with solid scientific fundamentals and products that promise reaching beyond the limiting horizon, we pinpointed ten to date. We picked them from among one hundred biotech firms that have little, or none of the properties that make out   super achievers. We decided to go on and start with a company called ChemoCentryx (CCXI). Our selection was not based on priority, preference, or any other reason that might insinuate advantages over the other nine firms we picked for comprehensive reviewing. It was rather based on curiosity triggered by a recent announcement by the firm of preclinical results of a small molecule oral drug CCX872 aimed at blocking the chemokine receptor CCR2 for the treatment of diabetes nephropathy.  More...


Recent Postings


Archive


Tags

Xoma (XOMA) Sequenom (SQNM) Sarepta (SRPT) Biogen Idec (BIIB) Vertex (VRTX) HALOZYME (HALO) Global Cell Therapeutics (GBT) Sangamo (SGMO) Prosensa (RNA) Dendreon (DNDN) Roche (RHHBY) Jazz Pharmaceuticals (JAZZ) Tysabri REGULUS (RGLS) VANDA (VNDA) MODERNA Dynavax (DVAX) Intermune (ITMN) Idenix (IDIX) Cytokinetics (CYTK) Zerenex Endometrial Cancer Inovio (INO) galapagos (GLPG) IDERA (IDRA) SERES THERAPEUTICS (MCRB) Sanofi (SNY) Sanofi-Aventis (SAN) BIOMARIN (BMRN) Abbott Laboratories (ABT) Intrexon (XON) Spike Therapeutics (ONCE) Sanofi (SNA) KITE (KITE) Biocryst (BCRX) Human Longevity (HLI) RenenxBio (RGNX) Exelixis (EXEL) Ariad (ARIA) SYNTA (SNTA) Anacor (ANAC) GUARDIAN HEALTH Pluristem (PSTI) NEKTAR (NKTR)) Herceptin Adaptimmune (ADAP) Micromet (MITI) Human Genome Sciences (HGSI) Editas (EDIT) Vitae Pharmaceuticals (VTAE) Incyte (INCY) Ionis (IONS) Galena (GALE) Revlimid (lenolidamide) Seattle Genetics (SGEN) Advaxis (ADXS) Amgen (AMGN) Roche (ROCHE) TOKAI (TKAOI) Illumina (ILMN) Gilead (GILD) Theravance Bio Pharma (TBPH) SUNESIS PHARMACEUTICALS (SNSS) Array Pharmaceuticals (ARRY) Elan (ELN) Multiple Myeloma Merck (MRK) Agenus (AGEN) Aimmune Therapeutics (AIMT) ARCA (ABIO) Agenus (AGEN Benlysta (belimumab) NANTKWEST (NK) KERYX (KERX) Rapamune Ridaforolimus Bristol-Myers Squibb (BMY) NOVOCURE (NVCR) ACADIA (ACAD) Velcade (bortezomib) ADVENTRIX (ANX) Genentech Alnylam (ALNY) Anadys (ANDS) PTC Therapeutics (PTCT) ISIS (ISIS) Intercept (ICPT) Alder Biopharmaceuticals (ALDR) Telaprevir AGOS (ARGS) Ziofpharm (ZIOP) JUNO (JUNO) Regeneron (REGN) ABBVIE (ABBV) ZALTRAP™ CRISPR Therapeutics (CRSP) Prolor Biotech (PBTH) AstraZeneca (AZN) Bellicum (BLCM) Valeant Pharmaceuticals International (VRX) Theravance (THRX) GlaxoSmithKline (GSK) CompuGen (CGEN) ImmunoGen (IMGN) INNOVIVA (INVA) Trastuzumab-DM1 Onyx (ONXX) ARGOS (ARGS) Auspex (ASPX) AERIE PHARMACEUTICALS C4 Therapeutics OSI (OSIP) Mirati Therapeutics (MRTX)